医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicity.

广告
第一作者: Shuhei,Tsujino
第一单位: Department of Virology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.;Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
作者单位: Department of Virology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.;Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan. [1] Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.;Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo, Japan. [2] Department of Synthetic Human Body System, Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo, Tokyo, Japan.;Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan. [3] Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.;International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. [4] Gladstone Institutes, San Francisco, CA, USA.;Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA. [5] Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan. [6] Gladstone Institutes, San Francisco, CA, USA. [7] Department of Virology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.;Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.;Institute for Vaccine Research and Development (IVReD), Hokkaido University, Sapporo, Japan. [8] Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan. [9] Gladstone Institutes, San Francisco, CA, USA.;Department of Medicine, University of California, San Francisco, CA, USA.;Chan Zuckerberg Biohub-San Francisco, San Francisco, CA, USA. [10] Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.;International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.;Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.;Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.;International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.;Collaboration Unit for Infection, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto, Japan.;MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.;Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore. [11] Department of Synthetic Human Body System, Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo, Tokyo, Japan. takayama.kazuo@tmd.ac.jp.;Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan. takayama.kazuo@tmd.ac.jp.;AMED-CREST, Japan Agency for Medical Research and Development (AMED), Tokyo, Japan. takayama.kazuo@tmd.ac.jp. [12] Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan. tanaka@med.hokudai.ac.jp.;Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo, Japan. tanaka@med.hokudai.ac.jp. [13] Department of Virology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan. tamura.tomokazu.956@m.kyushu-u.ac.jp.;Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan. tamura.tomokazu.956@m.kyushu-u.ac.jp.;Institute for Vaccine Research and Development (IVReD), Hokkaido University, Sapporo, Japan. tamura.tomokazu.956@m.kyushu-u.ac.jp.;Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan. tamura.tomokazu.956@m.kyushu-u.ac.jp.;One Health Research Center, Hokkaido University, Sapporo, Japan. tamura.tomokazu.956@m.kyushu-u.ac.jp. [14] Department of Virology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan. fukuhara.takasuke.169@m.kyushu-u.ac.jp.;Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University, Sapporo, Japan. fukuhara.takasuke.169@m.kyushu-u.ac.jp.;Institute for Vaccine Research and Development (IVReD), Hokkaido University, Sapporo, Japan. fukuhara.takasuke.169@m.kyushu-u.ac.jp.;AMED-CREST, Japan Agency for Medical Research and Development (AMED), Tokyo, Japan. fukuhara.takasuke.169@m.kyushu-u.ac.jp.;One Health Research Center, Hokkaido University, Sapporo, Japan. fukuhara.takasuke.169@m.kyushu-u.ac.jp.;Laboratory of Virus Control, Research Institute for Microbial Diseases, The University of Osaka, Suita, Japan. fukuhara.takasuke.169@m.kyushu-u.ac.jp. [15]
DOI 10.1038/s41467-025-67455-4
PMID 41392175
发布时间 2026-03-06
提交
  • 浏览0
Nature communications

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷